Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Measurable residual disease (MRD) monitoring for mutated NPM1 is increasingly used to guide treatment decisions in patients with acute myeloid leukemia (AML) carrying this mutation. NPM1-MRD positivity after induction has been shown to identify patients who may benefit from allogeneic hematopoietic cell transplantation (allo-HCT), and NPM1-MRD monitoring after allo-HCT can detect early relapse, enabling the prompt initiation of salvage therapy. However, recommendations for clinical decision-making based on peritransplant NPM1-MRD levels are missing. In this study, we retrospectively analyzed 172 patients with NPM1-mutant AML treated at 2 German centers to explore the predictive values of NPM1-MRD measured before and after allo-HCT. We found that pretransplant MRD negativity was a strong predictor of favorable long-term overall survival (OS). In contrast, patients with positive and negative NPM1-MRD status at day 30 after HCT showed comparable OS. Finally, statistically derived NPM1-MRD thresholds effectively stratified MRD-high and MRD-low patient groups with differential outcome, with 2 peritransplant MRD risk scores obtained by longitudinal integration. First, a combined score using MRD measurements before HCT and at day 30 HCT was used to guide early reduction of immunosuppression (concordance index [C-index], 0.737). Second, a combined score using MRD measurements before HCT and at day 30 and day 100 after HCT was used to guide later post-HCT interventions (C-index, 0.841; stratified 2-year OS groups, 100%, 90.1%, 57.1%, and 25.7%; P< .0001). This approach predicted OS better than age, FLT3-ITD status, or morphological remission status. We propose that in the peritransplant setting, NPM1-MRD thresholds are superior to conventional MRD analysis based on binary or log-step change data.